Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 69


Proteomic Analysis of Embryonic and Young Human Vitreous.

Yee KM, Feener EP, Madigan M, Jackson NJ, Gao BB, Ross-Cisneros FN, Provis J, Aiello LP, Sadun AA, Sebag J.

Invest Ophthalmol Vis Sci. 2015 Nov 1;56(12):7036-42. doi: 10.1167/iovs.15-16809.


Negatively charged silver nanoparticles cause retinal vascular permeability by activating plasma contact system and disrupting adherens junction.

Long YM, Zhao XC, Clermont AC, Zhou QF, Liu Q, Feener EP, Yan B, Jiang GB.

Nanotoxicology. 2015 Sep 23:1-11. [Epub ahead of print]


Thrombosis and Hemorrhage in Diabetic Retinopathy: A Perspective from an Inflammatory Standpoint.

Murugesan N, √ústunkaya T, Feener EP.

Semin Thromb Hemost. 2015 Sep;41(6):659-64. doi: 10.1055/s-0035-1556731. Epub 2015 Aug 25.


Plasma Kallikrein-Kinin System as a VEGF-Independent Mediator of Diabetic Macular Edema.

Kita T, Clermont AC, Murugesan N, Zhou Q, Fujisawa K, Ishibashi T, Aiello LP, Feener EP.

Diabetes. 2015 Oct;64(10):3588-99. doi: 10.2337/db15-0317. Epub 2015 May 15.


Thioredoxin-interacting protein regulates protein disulfide isomerases and endoplasmic reticulum stress.

Lee S, Min Kim S, Dotimas J, Li L, Feener EP, Baldus S, Myers RB, Chutkow WA, Patwari P, Yoshioka J, Lee RT.

EMBO Mol Med. 2014 May 19;6(6):732-43. doi: 10.15252/emmm.201302561.


Serine phosphorylation sites on IRS2 activated by angiotensin II and protein kinase C to induce selective insulin resistance in endothelial cells.

Park K, Li Q, Rask-Madsen C, Mima A, Mizutani K, Winnay J, Maeda Y, D'Aquino K, White MF, Feener EP, King GL.

Mol Cell Biol. 2013 Aug;33(16):3227-41. doi: 10.1128/MCB.00506-13. Epub 2013 Jun 17.


Role of plasma kallikrein in diabetes and metabolism.

Feener EP, Zhou Q, Fickweiler W.

Thromb Haemost. 2013 Sep;110(3):434-41. doi: 10.1160/TH13-02-0179. Epub 2013 May 16. Review.


Plasma kallikrein-kinin system and diabetic retinopathy.

Liu J, Feener EP.

Biol Chem. 2013 Mar;394(3):319-28. doi: 10.1515/hsz-2012-0316. Review.


Intraocular hemorrhage causes retinal vascular dysfunction via plasma kallikrein.

Liu J, Clermont AC, Gao BB, Feener EP.

Invest Ophthalmol Vis Sci. 2013 Feb 7;54(2):1086-94. doi: 10.1167/iovs.12-10537.


Measurement of pulsatile total blood flow in the human and rat retina with ultrahigh speed spectral/Fourier domain OCT.

Choi W, Baumann B, Liu JJ, Clermont AC, Feener EP, Duker JS, Fujimoto JG.

Biomed Opt Express. 2012 May 1;3(5):1047-61. doi: 10.1364/BOE.3.001047. Epub 2012 Apr 19.


The voltage-gated proton channel Hv1 enhances brain damage from ischemic stroke.

Wu LJ, Wu G, Akhavan Sharif MR, Baker A, Jia Y, Fahey FH, Luo HR, Feener EP, Clapham DE.

Nat Neurosci. 2012 Mar 4;15(4):565-73. doi: 10.1038/nn.3059.


Deletion of thioredoxin-interacting protein in mice impairs mitochondrial function but protects the myocardium from ischemia-reperfusion injury.

Yoshioka J, Chutkow WA, Lee S, Kim JB, Yan J, Tian R, Lindsey ML, Feener EP, Seidman CE, Seidman JG, Lee RT.

J Clin Invest. 2012 Jan;122(1):267-79. doi: 10.1172/JCI44927. Epub 2011 Dec 27.


Inhibition of insulin signaling in endothelial cells by protein kinase C-induced phosphorylation of p85 subunit of phosphatidylinositol 3-kinase (PI3K).

Maeno Y, Li Q, Park K, Rask-Madsen C, Gao B, Matsumoto M, Liu Y, Wu IH, White MF, Feener EP, King GL.

J Biol Chem. 2012 Feb 10;287(7):4518-30. doi: 10.1074/jbc.M111.286591. Epub 2011 Dec 12.


mTOR kinase domain phosphorylation promotes mTORC1 signaling, cell growth, and cell cycle progression.

Ekim B, Magnuson B, Acosta-Jaquez HA, Keller JA, Feener EP, Fingar DC.

Mol Cell Biol. 2011 Jul;31(14):2787-801. doi: 10.1128/MCB.05437-11. Epub 2011 May 16.


Plasma kallikrein mediates retinal vascular dysfunction and induces retinal thickening in diabetic rats.

Clermont A, Chilcote TJ, Kita T, Liu J, Riva P, Sinha S, Feener EP.

Diabetes. 2011 May;60(5):1590-8. doi: 10.2337/db10-1260. Epub 2011 Mar 28.


Hyperglycemia-induced cerebral hematoma expansion is mediated by plasma kallikrein.

Liu J, Gao BB, Clermont AC, Blair P, Chilcote TJ, Sinha S, Flaumenhaft R, Feener EP.

Nat Med. 2011 Feb;17(2):206-10. doi: 10.1038/nm.2295. Epub 2011 Jan 23.


Proteomic identification of novel plasma kallikrein substrates in the astrocyte secretome.

Liu J, Gao BB, Feener EP.

Transl Stroke Res. 2010 Dec;1(4):276-86. doi: 10.1007/s12975-010-0039-z. Epub 2010 Aug 28.


Vitreous proteomics and diabetic retinopathy.

Walia S, Clermont AC, Gao BB, Aiello LP, Feener EP.

Semin Ophthalmol. 2010 Sep-Nov;25(5-6):289-94. doi: 10.3109/08820538.2010.518912. Review.


Plasma kallikrein and diabetic macular edema.

Feener EP.

Curr Diab Rep. 2010 Aug;10(4):270-5. doi: 10.1007/s11892-010-0127-1.


Identification of a novel phosphorylation site on TBC1D4 regulated by AMP-activated protein kinase in skeletal muscle.

Treebak JT, Taylor EB, Witczak CA, An D, Toyoda T, Koh HJ, Xie J, Feener EP, Wojtaszewski JF, Hirshman MF, Goodyear LJ.

Am J Physiol Cell Physiol. 2010 Feb;298(2):C377-85. doi: 10.1152/ajpcell.00297.2009. Epub 2009 Nov 18.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk